Coordinate up-regulation of low-density lipoprotein receptor and cyclo- oxygenase-2 gene expression in human colorectal cells and in colorectal adenocarcinoma biopsies

International Journal of Cancer

Volumn 83, Issue 2, 1999, Pages 162-166

  Lum, Donald F ^a,b   Mcquaid, Kenneth R ^a,b   Gilbertson, Vicki L ^b,c   Hughes Fulford, Millie ^a,b,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; PROSTAGLANDIN SYNTHASE;

ADENOCARCINOMA; ARTICLE; CANCER GROWTH; COLON BIOPSY; COLORECTAL CARCINOMA; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIPID TRANSPORT; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

NASA DISCIPLINE CELL BIOLOGY; NON-NASA CENTER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL DIVISION; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEEDBACK; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; LIPOPROTEINS, LDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, LDL; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032881207     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991008)83:2<162::AID-IJC3>3.0.CO;2-W     Document Type: Article

References (23)

1. AWAD, A.B., FINK, C.S. and HORVATH, P.J., Alteration of membrane fatty acid composition and inositol phosphate metabolism in HT-29 human colon cancer cells. Nutr. Cancer, 19, 181-190 (1993).
2. AXELSON, M. and LARSSON, O., 27-Hydroxylated low density lipoprotein (LDL) cholesterol can be converted to 7alpha,27-dihydroxy-4-cholesten-3-one (cytosterone) before suppressing cholesterol production in normal human fibroblasts. Evidence that an altered metabolism of ldl cholesterol can underline a defective feedback control in malignant cells. J. biol. Chem., 31, 12724-12736 (1996).
3. CARUSSO, M.G., NOTARNICOLA, M., CAVALLINI, A., GUERRA, V., MISCIANGNA, G. and DI LEO, A., Demonstration of low density lipoprotein receptor in human colonic carcinoma and surrounding mucosa by immunoenzymatic assay. Ital. J Gastroenterol., 25, 361-367 (1993).
4. EBERHART, C.E., COFFEY, R.J., RADHIKA, A., GIARDIELLO, F.M., FERRENBACH, S. and DUBOIS, S.R., Up-regulation of cyclo-oxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188 (1994).
5. GIARDIELLO, F.M., HAMILTON, S.R., KRUSH, A.J., PIANTADOSSI, S., HYLIND, L.M., CELANO, P., BOOKER, S.V., ROBINSON, C.R. and OFFERHAUS, G.J.A., Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316 (1993).
6. GIOVANNUCCI, E., RIMM, E.B., STAMPFER, M.J., COLDITZ, G.A., ASCHERIO, A. and WILLIET, W.C., Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. intern. Med., 121, 241-246 (1994).
7. GROSS, M.E., ZORBAS, M.A., DANIELS, Y.J., GARCIA, R., GALLICK, G.E., BRATTAIN, M.G., BOMAN, B.M. and YEOMAN, L.C., Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Cancer Res., 51, 1452-1459 (1991).
8. GUEDDARI, N., FAVRE, G., HACHEM, H., MAREK, E., LE GAILLARD, F. and SOULA, G., Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie, 75, 811-819 (1993).
9. HABENICHT, A.J.R., SALBACH, P., GOERIG, M., ZEH, W., JANSSEN-TIMMEN, U., BLATTNER, C., KING, W.C. and GLOMSET, J.A., The LDL receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by platelet-derived growth factor. Nature (Lond.), 345, 634-636 (1990).
10. HABENICHT, A.J.R., SALBACH, P. and JANSSSEN-TIMMEN, U., LDL receptor-dependent polyunsaturated fatty acid transport and metabolism. Eicosanoids, 5 (Suppl.), 529-531 (1992).
11. KARGMAN, S.L., O'NEILL, G.P., VICKERS, P.J., EVANS, J.F., MANCINI, J.A. and JOTHY, S., Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 2556-2559 (1995).
12. LABAYLE, D., FISCHER, D., VIELH, P., DROUHIN, F., PARIENTE, A., BORIES, C., DUHAMEL, O., TROUSSET, M. and ATTALI, P., Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101, 635-639 (1991).
13. MILLER, S.R., TARTTER, P.I., PAPATESTAS, A.E., SLATER, G. and AUFSES, A.H., JR., Serum cholesterol and human colon cancer. J. nat. Cancer Inst., 67, 297-300 (1981).
14. NICHOLSON, M.L., NEOPTOLEMOS, J.P., CLAYTON, H.A., TALBOT, I.C. and BELL, P.R.F., Increased cell membrane arachidonic acid in experimental colorectal tumors. Gut, 32, 413-418 (1991).
15. REDDY, B.S., Dietary fat and colon cancer: animal model studies. Lipids, 27, 807-813 (1992).
16. STEPHAN, Z.F. and YURACHEK, E.C., Rapid fluorometric assay of LDL receptor activity by Dil-labeled LDL. J. Lipid Res., 34, 325-330 (1993)
17. THUN, M.J., NAMBOODIRI, M.M. and HEATH, C.W., JR., Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596 (1991).
18. 2 in prostate cancer. Adv. exp. Med. Biol., 407, 163-170 (1997).
19. 2 in prostate cancer. Brit. J. Cancer, 75, 1111-1118 (1997).
20. WILLIAMS, R.R., SORLIE, P.D., FEINLEIB, M., MCNAMURA, P.M., KANNEL, W.B. and DAWBER, T.R., Cancer incidence by levels of cholesterol. J. Amer. med. Ass., 245, 247-252 (1981).
21. WINGO, P.A., TONG, T. and BOLDEN, S., Cancer statistics. CA Cancer J. Clin., 8, 8-30 (1995).
22. YEN, C.F., KALUNTA, C.I., CHEN, F.S., KAPTEIN, J.S., LIN, C.K. and LAD, P.M., Regulation of low-density lipoprotein receptors and assessment of their functional role in Burkitt's lymphoma cells. Biochim. biophys. Acta, 1257, 47-57 (1995).
23. YEUNG, K.S. and 14 OTHERS, Comparison of diet and biochemical characteristics of stool and urine between Chinese populations with low and high colorectal cancer rates. J. nat. Cancer Inst., 83, 46-50 (1991).